Gross Law Firm Issues Notice to Shareholders of Alto Neuroscience

Strategic Insights -

The Gross Law Firm has issued a notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO), urging those who purchased shares of the company during the class period to contact the firm regarding possible lead plaintiff appointment. The allegations against Alto Neuroscience include the company issuing false and misleading statements about its product pipeline, ALTO-100, and its effectiveness in treating major depressive disorder.

Key Takeaways:

  • The notice applies to shareholders who purchased Alto common stock between February 2, 2024, and October 22, 2024, inclusive.
  • The complaint alleges that Alto Neuroscience's product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe.
  • The investigation alleges that Alto's public statements were materially false and misleading during the class period.
  • The Gross Law Firm seeks recovery on behalf of investors who incurred losses due to false and misleading statements by Alto Neuroscience.
  • The deadline to seek to be a lead plaintiff is September 19, 2025.

Statistics:

  • Class period: February 2, 2024, to October 22, 2024.
  • September 19, 2025, is the deadline to appoint a lead plaintiff.
  • The Gross Law Firm has a mission to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.

Sources:

  • " Gross Law Firm Issues the Following Notice to Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) - Alto Neuroscience, Inc. Class Action Lawsuit (ANRO) - Shareholder Class Action Lawsuit - PR Newswire"
  • "Contact Us: The Gross Law Firm, 15 West 38th Street, 12th floor, New York, NY, 10018, dg@securitiesclasslaw.com, Phone: 646-453-8903"
  • " Alto Neuroscience, Inc.'s (NYSE: ANRO) Class Action Lawsuit - Alto Common Stock (ANRO)"